# US 2015/0105751 A1 · Multiple reservoir drug delivery device and methods

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2015/0105751 A1
- Document ID: US20150105751A1
- Status: Published application
- Kind: A1
- Application number: 14/577,291
- Filed: 2014-12-19
- Published: 2015-04-16
- Earliest claimed: 2012-09-27
- Assignees: Palo Alto Research Center Incorporated
- Applicants: Palo Alto Research Center Incorporated
- Inventors: Scott A. Uhland; Ramkumar Abhishek; Eric Peeters; Timothy J. Curley; Felicia Linn
- Web page: https://patentgrep.com/patent/US20150105751A1

## CPC

- A61B 17/43: for artificial insemination
- A61D 7/00: Devices or methods for introducing solid, liquid or gaseous remedies or other materials into or onto the bodies of animals (for reproduction or fertilisation A61D19/00)
- A61D 19/024: {Tube-like containers, e.g. straws}
- A61D 19/027: {Devices for injecting semen into animals, e.g. syringes, guns, probes}
- A61K 9/0004: {Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas}
- A61K 9/0034: {Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants}
- A61M 5/1408: {in parallel, e.g. by manifolds or with sequencing valves}
- A61M 5/145: using pressurised reservoirs, e.g. by means of pistons
- A61M 5/155: pressurised by gas {introduced into the reservoir}
- A61M 5/16827: {controlling delivery of multiple fluids, e.g. sequencing, mixing or via separate flow-paths (infusion of multiple fluids without using a controller A61M5/1407)}
- A61M 31/00: Devices for introducing or retaining media, e.g. remedies, in cavities of the body (A61M25/00 takes precedence {; introducing or retaining ophthalmic products into the ocular cavities A61F9/0008})
- A61M 2005/14204: {with gas-producing electrochemical cell}
- A61M 2210/1042: Alimentary tract (A61M2210/0618 takes precedence)
- A61M 2210/1085: Bladder
- A61M 2210/1433: Uterus
- A61M 2210/1475: Vagina
- A61B: DIAGNOSIS; SURGERY; IDENTIFICATION (usefulness limited to only animals A61D)
- A61D: VETERINARY INSTRUMENTS, IMPLEMENTS, TOOLS, OR METHODS
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61M: DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY (introducing media into or onto the bodies of animals A61D7/00; means for inserting tampons A61F13/26; devices for administering food or medicines orally A61J; containers for collecting, storing or administering blood or medical fluids A61J1/05); DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY (surgery A61B; chemical aspects of surgical articles A61L); DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR {(Electrotherapy, e.g. producing anaesthesia by the use of alternating or intermittent currents A61N1/36021)}

## Abstract

Devices and methods are provided for drug delivery. The device may include a housing configured for intraluminal deployment into a human or animal subject and first and second reservoirs within the housing, each reservoir having an actuation end, an opposed release end, and a plug moveable from the actuation end toward the release end. First and second drug formulations may be contained in the first and second reservoirs, respectively. The device may also include one or more actuation systems configured to drive the first and second plugs so as to drive the first and second drug formulations from the first and second reservoirs. The housing may include a porous membrane sidewall in fluid communication with the release ends of the first and second reservoirs, the porous membrane sidewall being configured to distribute the first and second drug formulations driven from the first and second reservoirs.

## Claims

### Claim 1

A method of drug delivery comprising:
deploying a drug delivery device into a mucosal lumen of a human or animal subject, the drug delivery device comprising a first reservoir containing a first drug formulation, a second reservoir containing a second drug formulation, and a porous membrane sidewall adjacent the mucosal lumen;
actuating one or more actuation systems to drive the first and second drug formulations out of the first and second reservoirs and into the porous membrane sidewall; and
releasing the first and second drug formulations from the porous membrane sidewall to the mucosal lumen.

### Claim 2 (depends on 1)

The method of claim 1, wherein the actuating one or more actuation systems comprises:
actuating a single actuation system to drive the first drug formulation out of the first reservoir; and thereafter
actuating the single actuation system to drive the second drug formulation out of the second reservoir.

### Claim 3 (depends on 1)

The method of claim 1, wherein the actuating one or more actuation system comprises using at least one electrolytic cell to generate a displacement gas to drive the first and second drug formulations out of the first and second reservoirs.

### Claim 4 (depends on 1)

The method of claim 1, wherein release of the first drug formulation from the first reservoir is completed before any of the second drug formulation is released from the second reservoir.

### Claim 5 (depends on 1)

The method of claim 1, wherein release of the first drug formulation from the first reservoir overlaps with release of the second drug formulation from the second reservoir.

### Claim 6 (depends on 1)

The method of claim 1, wherein:
the device comprises a housing configured for intraluminal deployment, the first and second reservoirs being located within the housing,
the first reservoir contains a first plug and the second reservoir contains a second plug, and
actuating the one or more actuation systems to drive the first and second drug formulations out of the first and second reservoirs comprises driving the first and second plugs so as to drive the first and second drug formulations out of the first and second reservoirs.

### Claim 7 (depends on 1)

The method of claim 1, wherein the mucosal lumen is the vagina, cervix, uterus, bladder, or rectum of the human or animal subject.
